ConductScience.org, home

Paper40423909

Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.

Kim KM and 8 others. Blood Res, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Cell-based artificial platelet production: historical milestones, emerging trends, and future directions. Papers, record 40423909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40423909

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.
PubMed
Journal
Blood Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.55, provisional
iCite
Revised in PubMed
2025-05-31
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim KMKyoung Mi
2Albaira KIKoudai I
3Kang JJayoung
4Cho YGYong Gon
5Kwon SSSoon Sung
6Lee JJaecheol
7Ko DHDae-Hyun
8Kim SSinyoung
9Lee SYSeung Yeob

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
RS-2023-KH140972, HX23C1706
Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety
PubMed
NRF-2022R1C1C1011518National Research FoundationPubMed
NRF-2022R1C1C1011518National Research FoundationPubMed
NRF-2022R1C1C1011518National Research FoundationPubMed
NRF-2022R1I1A2070940National Research FoundationPubMed
NRF-2022R1C1C1011518National Research FoundationPubMed
RS-2023-00236157Bio&Medical Technology Development Program of the NRF funded by the Korean government (MSIT)PubMed
RS-2023-00236157Bio&Medical Technology Development Program of the NRF funded by the Korean government (MSIT)PubMed

Source PubMed

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137294031Current status of platelet manufacturing in 3D or bioreactors.Biotechnol Prog2023https://conductscience.org/library/papers/37294031PubMed
225606631Platelet bioreactor-on-a-chip.Blood2014https://conductscience.org/library/papers/25606631PubMed
320412529Generation of HLA-deficient platelets from hematopoietic progenitor cells.Transfusion2010https://conductscience.org/library/papers/20412529PubMed
430487128Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.Blood2019https://conductscience.org/library/papers/30487128PubMed
523618622Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.Exp Hematol2013https://conductscience.org/library/papers/23618622PubMed
638847904Preoperative consultation for determining the appropriate transfusion strategy.Blood Res2024https://conductscience.org/library/papers/38847904PubMed
732439978Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.Sci Rep2020https://conductscience.org/library/papers/32439978PubMed
834777386Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering.Front Immunol2021https://conductscience.org/library/papers/34777386PubMed
936149941Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.Blood Adv2022https://conductscience.org/library/papers/36149941PubMed
1012920021Production of functional platelets by differentiated embryonic stem (ES) cells in vitro.Blood2003https://conductscience.org/library/papers/12920021PubMed
1130047825In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells.Platelets2018https://conductscience.org/library/papers/30047825PubMed
1210029169Cord blood is better than bone marrow for generating megakaryocytic progenitor cells.Exp Hematol1999https://conductscience.org/library/papers/10029169PubMed
139446643Effects of cytokines on platelet production from blood and marrow CD34+ cells.Blood1998https://conductscience.org/library/papers/9446643PubMed
147529062Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.Blood1995https://conductscience.org/library/papers/7529062PubMed
1516420577Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function.J Thromb Haemost2006https://conductscience.org/library/papers/16420577PubMed
1626898346Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics.Sci Rep2016https://conductscience.org/library/papers/26898346PubMed
1734360992Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production.Int J Mol Sci2021https://conductscience.org/library/papers/34360992PubMed
1816904174Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell2006https://conductscience.org/library/papers/16904174PubMed
1932158298Platelet Transfusion: And Update on Challenges and Outcomes.J Blood Med2020https://conductscience.org/library/papers/32158298PubMed
2010863976CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells.Eur J Haematol2000https://conductscience.org/library/papers/10863976PubMed

See all 58 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42427961From Donation to Innovation: New Blood-Derived Products.Transfus Med Hemother2026https://conductscience.org/library/papers/42427961PubMed
41897498Redox Regulation of Megakaryocyte Differentiation and Platelet Biogenesis.Antioxidants (Basel)2026https://conductscience.org/library/papers/41897498PubMed
41463354Proteomic Validation of MEG-01-Derived Extracellular Vesicles as Representative Models for Megakaryocyte- and Platelet-Derived Extracellular Vesicles.Biomolecules2025https://conductscience.org/library/papers/41463354PubMed
40938731Induction of moderate DNA damage enhances megakaryopoiesis and platelet production.Blood Adv2026https://conductscience.org/library/papers/40938731PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40423909

GET https://conductscience.org/api/papers/v1/40423909/references?page=2